Aristolochic acid nephropathy, a global health problem

March 19, 2013
Aristolochic acid nephropathy, a global health problem
Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid found in Chinese herbs was first reported 20 years ago, aristolochic acid-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

(HealthDay)—Although the first description of a rapidly progressive nephropathy associated with the consumption of aristolochic acid (AA) found in Chinese herbs was first reported 20 years ago, AA-induced nephropathy remains a worldwide health concern due to the lack of regulation on herbal medication and the easy availability of such medications online, according to a review published in the March 19 issue of the Annals of Internal Medicine.

M. Refik Gokmen, Ph.D., M.B.B.S., of King's College London and Imperial College London, and colleagues used an evidence-based approach to review the epidemiology, diagnosis, and management of AA-induced .

According to the authors, herbal medicinal products containing AA have been, and continue to be, used worldwide for various indications such as eczema, acne, liver symptoms, arthritis, and chronic pain. The exact mechanisms of AA-induced nephrotoxicity are not fully characterized. Most patients diagnosed with AA-induced nephropathy showed an unusually rapid progression toward end-stage renal disease. Cumulative AA dose is likely associated with the degree of renal insufficiency and the rate of decline in renal function. No serum or urinary biomarkers have been shown to aid in the diagnosis of AA-induced nephropathy. can only be made with histological examination. There are no known therapeutic agents that can reverse or delay progression of AA-induced nephropathy.

"We have attempted in this review to fill in the many evidence gaps about all aspects of this disease on the basis of our clinical experience and consensus, but future research should seek to determine noninvasive biomarkers of exposure and disease and optimum agents and surgical treatments that might alter the course of the disease," the authors write. "Perhaps most important, improved regulation of could help eradicate this entirely preventable illness."

Explore further: Rapidly progressive alopecia shows favorable prognosis

More information: Full Text (subscription or payment may be required)

Related Stories

Rapidly progressive alopecia shows favorable prognosis

October 9, 2012
(HealthDay)—Patients with rapidly progressive alopecia areata (RPAA) tend to show favorable prognosis regardless of treatment selected, according to research published online Sept. 24 in the Journal of the American Academy ...

Herbal remedy blamed for high cancer rate in Taiwan: study

April 9, 2012
A toxic ingredient in a popular herbal remedy is linked to more than half of all cases of urinary tract cancer in Taiwan where use of traditional medicine is widespread, said a US study Monday.

Millions of people in Asia potentially exposed to health risks of popular herbal medicines

March 18, 2013
Scientists from King's College London are warning that millions of people may be exposed to risk of developing kidney failure and bladder cancer by taking herbal medicines that are widely available in Asia. The medicines, ...

Low ratio of n3:n6 fatty acids correlates with CAD progression

January 23, 2013
(HealthDay)—For statin-treated patients with coronary artery disease, decreases in the ratio of serum n-3 to n-6 polyunsaturated fatty acids (PUFAs) correlate with atherosclerosis progression, according to research published ...

New study challenges current thinking on risk factors for contrast induced nephrotoxicity

May 1, 2012
Contrary to current belief, a new study finds that patients with a history of diabetes are not one of the most at risk for contrast induced nephrotoxicity. Instead, the study found that patients with a history of renal disease, ...

Research aims to prevent diabetic kidney failure

November 5, 2011
The enzyme arginase-2 plays a major role in kidney failure, and blocking the action of this enzyme might lead to protection against renal disease in diabetes, according to researchers.

Recommended for you

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

Fresh approach to tuberculosis vaccine offers better protection

January 17, 2018
A unique platform that resulted in a promising HIV vaccine has also led to a new, highly effective vaccine against tuberculosis that is moving toward testing in humans.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.